<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00599807</url>
  </required_header>
  <id_info>
    <org_study_id>PP00B-114864</org_study_id>
    <secondary_id>2007DR4347</secondary_id>
    <nct_id>NCT00599807</nct_id>
  </id_info>
  <brief_title>Zurich Multiple Endpoint Vitamin D Trial in Knee OA Patients</brief_title>
  <official_title>Role of Vitamin D in Secondary Prevention of Knee Osteoarthritis: A Double-blind Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Harvard School of Public Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tufts University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a 2-year double-blind randomized controlled trial in 287 community-dwelling
      individuals age 60 years or older undergoing uni-lateral total knee replacement due to severe
      OA of the knee.We compare an oral dose of 2000 IU vitamin D3 per day to 800 IU. The primary
      endpoints are pain and disability related to rehabilitation of the operated knee,and related
      to the expected high prevalence of OA in the contra-lateral knee. Secondary endpoints are
      change in 25(OH)D levels, muscle strength, balance, lower extremity function, the rate of
      falls, bone density and bone quality, bone metabolism, general pain, fall-related fractures,
      body composition, blood-pressure, major cardiovascular events, blood glucose-insulin levels,
      executive cognitive function, rate of upper respiratory tract infections / all infections,
      tooth loss, dental health, health care utilization, number and size of facial skin keratosis,
      and radiographic progression of the non-operated knee. Pain and disability will be assessed
      by the pain and function subscales of the Western Ontario- McMaster Universities
      Osteoarthritis Index (WOMAC). Randomization will be stratified by WOMAC function prior to
      surgery, radiological evidence for OA in the contra-lateral knee, and hospital. Clinical
      visits will take place at baseline (6-8 weeks after TKR), at 6, 12, 18 and 24 months of
      treatment. In addition, all individuals will receive a phone call every 2 month to assess
      adverse outcomes and compliance to treatment, supported by a hotline for immediate report of
      adverse events.

      Statistical power: We expect more than 80% power with 200 participants completing their 24
      month follow-up, and 260 participants completing their 12 month follow-up.

      This is a trial with medicinal product.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain and function of the operated and non-operated knee</measure>
    <time_frame>0, 6,12,18, 24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>rate of falls</measure>
    <time_frame>0, 24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>strength, balance, function, physical activity</measure>
    <time_frame>0,6,12,18,24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bone density, bone quality</measure>
    <time_frame>0, 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body composition</measure>
    <time_frame>0, 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>0,12,24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of teeth</measure>
    <time_frame>0, 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cost, health care utilization</measure>
    <time_frame>0,6,12,18,24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>facial skin keratosis (number and size)</measure>
    <time_frame>0, 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cognitive function</measure>
    <time_frame>0, 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>depression, mental health</measure>
    <time_frame>0,12,24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fasting blood glucose - insulin levels</measure>
    <time_frame>0,12,24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of upper respiratory infections and number of any infections</measure>
    <time_frame>0, 6,12,28,24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bone metabolism</measure>
    <time_frame>0,6,12,18,24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>radiographic progression of the non-operated knee</measure>
    <time_frame>0, 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>general pain</measure>
    <time_frame>0,6,12,18,24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>0,6,12,18,24</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">273</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>1: 2000 IU D3/day</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2000 IU vitamin D3 taken orally each day for 2 years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2: 800 IU D3 / day</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>800 IU vitamin D3 taken orally each day for 2 years</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3 (cholecalciferol)</intervention_name>
    <description>the intervention is a dietary supplement comparing the current standard (800 IU) to the current safe upper limit (2000 IU)</description>
    <arm_group_label>1: 2000 IU D3/day</arm_group_label>
    <arm_group_label>2: 800 IU D3 / day</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Unilateral knee replacement due to knee osteoarthritis

          -  Age 60+ years

          -  German language skills

          -  community dwelling

        Exclusion Criteria:

          -  Bi-lateral knee replacement or hip replacement planned in the trial period, or in the
             previous 6 months

          -  Chronic steroid intake

          -  Serum calcium corrected for serum albumin &gt; 2.6 mmol/l

          -  GFR &lt; 30 ml/min

          -  Severe visual or hearing impairment

          -  Inflammatory arthritis

          -  Malabsorption

          -  High alcohol intake

          -  Sarcoidosis, primary hyperparathyroidism

          -  History of kidney stones, lymphoma

          -  Chemotherapy for cancer in the previous 12 months

          -  Hemiplegia

          -  Morbus Parkinson

          -  Unable to walk 3 meters prior to surgery

          -  Bisphosphonate, parathyroid hormone , fluoride or calcitonine therapy in the last 6
             months

          -  Zolendronate in the last year

          -  M. Paget (Ostitis deformans)

          -  Vitamin D3 intake more than 800IU/d over more than 1 month

          -  stay on a sunny location for more than 6 weeks per year

          -  heart failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heike Bischoff-Ferrari, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Centre on Aging and Mobility</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Zurich, Centre on Aging and Mobility</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2008</study_first_submitted>
  <study_first_submitted_qc>January 23, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 24, 2008</study_first_posted>
  <last_update_submitted>October 27, 2014</last_update_submitted>
  <last_update_submitted_qc>October 27, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

